by Rimma Gerenstein, Albert-Ludwigs-Universität Freiburg im Breisgau Orally administered hBD-2 is detectable in organs of hBD-2-treated aGVHD mice. The allo-HCT major mismatch model C57BL/6→BALB/c was used. Mice were treated once daily with hBD-2 (n=5) or PBS (n=3) from day 0 until day 7. hBD-2 concentrations in organs were quantified by LC-MS/MS. Credit: Science Translational Medicine (2022). DOI:...
